<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               6 ADVERSE REACTIONS<BR>               <BR>                  Because clinical trials are conducted under widely varying conditions, adverse reactions rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.<BR>                  Safety evaluation of TARCEVA is based on more than 1200 cancer patients who received TARCEVA as monotherapy, more than 300 patients who received TARCEVA 100 or 150 mg plus gemcitabine, and 1228 patients who received TARCEVA concurrently with other chemotherapies. <BR>                  There have been reports of serious events, including fatalities, in patients receiving TARCEVA for treatment of NSCLC, pancreatic cancer or other advanced solid tumorsÂ  [see Warnings and Precautions (5) and Dosage and Administration (2.3)].<BR>                  <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           The most common adverse reactions (>20%) in maintenance treatment are rash-like events and diarrhea. (6)<BR>                           The most common adverse reactions (>20%) in 2nd line NSCLC are rash, diarrhea, anorexia, fatigue, dyspnea, cough, nausea, infection and vomiting. (6)<BR>                           The most common adverse reactions (>20%) in pancreatic cancer are fatigue, rash, nausea, anorexia, diarrhea, abdominal pain, vomiting, weight decrease, infection, edema, pyrexia, constipation, bone pain, dyspnea, stomatitis and myalgia. (6)<BR>                        <BR>                        <BR>                           To report SUSPECTED ADVERSE REACTIONS, contact OSI Pharmaceuticals, LLC at 1-800-572-1932 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.<BR>                           <BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.1 Clinical Trial Experience<BR>                     <BR>                        <BR>                           Non-Small Cell Lung Cancer<BR>                        <BR>                        <BR>                           Maintenance Study<BR>                        <BR>                        Adverse reactions, regardless of causality, that occurred in at least 3% of patients treated with single-agent TARCEVA at 150 mg and at least 3% more often than in the placebo group in the randomized maintenance trial are summarized by NCI-CTC (version 3.0) Grade in Table 1.<BR>                        The most common adverse reactions in patients receiving single-agent TARCEVA 150 mg were rash and diarrhea. Grade 3/4 rash and diarrhea occurred in 6.0% and 1.8%, respectively, in TARCEVA-treated patients. Rash and diarrhea resulted in study discontinuation in 1.2% and 0.5% of TARCEVA-treated patients, respectively. Dose reduction or interruption for rash and diarrhea was needed in 5.1% and 2.8% of patients, respectively. In TARCEVA-treated patients who developed rash, the onset was within two weeks in 66% and within one month in 81%.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="single" width="445.000" ID="id_3dfcd922-7bef-4612-a411-b53779f3001b"><BR>                           <caption ID="id_030d7c6c-3e5a-4662-b830-1cee689e124b">Table 1: NSCLC Maintenance Study: Adverse Reactions Occurring More Frequently (&#8805; 3%) in the Single-Agent TARCEVA Group than in the Placebo Group and in &#8805; 3% of Patients in the TARCEVA Group.</caption><BR>                           <col width="26.5%"/><BR>                           <col width="11.7%"/><BR>                           <col width="12.4%"/><BR>                           <col width="12.4%"/><BR>                           <col width="12.4%"/><BR>                           <col width="12.4%"/><BR>                           <col width="12.4%"/><BR>                           <tbody><BR>                              <tr ID="id_3540f31a-1235-4205-bc46-544bf465d39d"><BR>                                 <td align="left" valign="top" styleCode="Botrule Toprule Rrule Lrule"/><BR>                                 <td align="center" valign="top" colspan="3" styleCode="Botrule Rrule"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">TARCEVA</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">N = 433</content><BR>                                 </td><BR>                                 <td align="center" valign="top" colspan="3" styleCode="Botrule Rrule"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">PLACEBO</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">N = 445</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_7b930761-0031-442b-9652-3c701b30aec4"><BR>                                 <td align="left" valign="middle" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">NCI-CTC Grade</content><BR>                                 </td><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Any Grade</content><BR>                                 </td><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Grade 3</content><BR>                                 </td><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Grade 4</content><BR>                                 </td><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Any Grade</content><BR>                                 </td><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Grade 3</content><BR>                                 </td><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Grade 4</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_ce39230b-97ee-4d7e-a775-4aa50e08bad4"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">MedDRA Preferred Term</content><BR>                                 </td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">%</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">%</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">%</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">%</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">%</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">%</td><BR>                              </tr><BR>                              <tr ID="id_2098cf2f-f7a1-4d02-834b-1c693b93717b"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Rash</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">49.2</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">6.0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">5.8</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_633920f2-380d-4bdf-940b-4997705d8115"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Diarrhea</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">20.3</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">1.8</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">4.5</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_1335ca46-fd49-4b58-85f9-987c819f2fef"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Fatigue</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">9.0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">1.8</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">5.8</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">1.1</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_9a8366c8-6dde-4a05-8240-63e5984cbbeb"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Anorexia</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">9.2</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">4.9</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_a25f1d86-cc68-4fae-a684-c6947407b7d0"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Pruritus</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">7.4</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">2.7</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_97a98a30-91b9-4053-aa2f-d064f8ac742c"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Acne</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">6.2</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_2c0bfcc4-328e-4c32-a14f-9642f63eecf3"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Dermatitis Acneiform</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">4.6</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">1.1</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_1cd020b0-3a1c-48a2-8bcb-8aee20ff462f"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Dry Skin</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">4.4</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_63e16bc7-5471-4c9d-8272-0af863749910"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Weight Decreased</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">3.9</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_b4ff2cd2-9246-402d-90b3-c4c12fe9cb9e"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Paronychia</td><BR>                                 <td align="left" valign="top" styleCode="Rrule">3.9</td><BR>                                 <td align="left" valign="top" styleCode="Rrule">&lt;1</td><BR>                                 <td align="left" valign="top" styleCode="Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Rrule">0</td><BR>                                 <td align="left" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>Liver function test abnormalities (including elevated alanine aminotransferase (ALT), aspartate aminotransferase (AST) and bilirubin) were observed in patients receiving single-agent TARCEVA 150 mg in the Maintenance study. Grade 2 (>2.5 â 5.0 x ULN) ALT elevations occurred in 2% and 1%, and Grade 3 (>5.0 â 20.0 x ULN) ALT elevations were observed in 1% and 0% of TARCEVA and placebo treated patients, respectively. The TARCEVAÂ  treatment group had Grade 2 (>1.5-3.0 x ULN) bilirubin elevations in 4% and Grade 3 (>3.0-10.0 x ULN) in <1% compared with <1% for both Grades 2 and 3 in the placebo group. TARCEVA dosing should be interrupted or discontinued if changes in liver function are severeÂ  [see Dosage and Administration (2.3)].<BR>                        <BR>                        <BR>                           Second/Third Line Study<BR>                        <BR>                        Adverse reactions, regardless of causality, that occurred in at least 10% of patients treated with single-agent TARCEVA at 150 mg and at least 3% more often than in the placebo group in the randomized trial of patients with NSCLC are summarized by NCI-CTC (version 2.0) Grade in Table 2. <BR>                        The most common adverse reactions in this patient population were rash and diarrhea. Grade 3/4 rash and diarrhea occurred in 9% and 6%, respectively, in TARCEVA-treated patients. Rash and diarrhea each resulted in study discontinuation in 1% of TARCEVA-treated patients. Six percent and 1% of patients needed dose reduction for rash and diarrhea, respectively. The median time to onset of rash was 8 days, and the median time to onset of diarrhea was 12 days.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="single" width="481.000" ID="id_9a4b2471-2b17-4c08-b6b9-883f4edd09ad"><BR>                           <caption ID="id_7aabd674-5a8c-4a96-b5d0-268d3cb0cf44">Table 2: NSCLC 2<sup>nd</sup>/3<sup>rd</sup> Line Study: Adverse Reactions Occurring More Frequently (&#8805; 3%) in the Single-agent TARCEVA 150 mg Group than in the Placebo Group and in &#8805;10% of Patients in the TARCEVA Group.</caption><BR>                           <col width="28.1%"/><BR>                           <col width="9.6%"/><BR>                           <col width="12.5%"/><BR>                           <col width="12.5%"/><BR>                           <col width="11.0%"/><BR>                           <col width="12.5%"/><BR>                           <col width="13.9%"/><BR>                           <tbody><BR>                              <tr ID="id_a9b3168b-b149-45bd-a2b1-b4daa1a15e9c"><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Toprule Rrule Lrule"/><BR>                                 <td align="center" valign="bottom" colspan="3" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">TARCEVA 150 mg<br/>N = 485</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" colspan="3" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Placebo<br/>N = 242</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_0946f04e-cd90-4c6c-a49f-093ae37e7888"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">NCI-CTC Grade</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Any Grade</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Grade 3</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Grade 4</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Any Grade</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Grade 3</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Grade 4</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_0fb318b6-1f99-40ad-b439-182d784be2a9"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">MedDRA&#160;Preferred&#160;Term</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_5842402e-d7d4-4c10-a96e-85540bdd0be4"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Rash</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">75</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">8</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">17</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_d7ae404f-daa7-45d7-954b-1a19b172a809"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Diarrhea</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">54</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">6</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">18</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_da40842b-3bd0-4531-9f7c-e1677d112237"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Anorexia</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">52</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">8</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">38</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">5</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                              </tr><BR>                              <tr ID="id_9ce9a13d-8a5a-4c50-8a94-ccf7c5f27c14"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Fatigue</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">52</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">14</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">4</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">45</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">16</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">4</td><BR>                              </tr><BR>                              <tr ID="id_5f5c48ea-0929-41c2-a74b-7b435c3d550b"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Dyspnea</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">41</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">17</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">11</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">35</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">15</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">11</td><BR>                              </tr><BR>                              <tr ID="id_ac869699-dca6-493d-858c-1d1cb07dc448"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Cough</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">33</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">4</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">29</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_a4fd8ac2-5b0b-4568-beb0-18ba3d36c0e1"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Nausea</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">33</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">3</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">24</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_5543795c-8b31-4fe5-93f5-5fd23e09aa69"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Infection</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">24</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">4</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">15</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_afc7c6d8-efc0-4d72-9904-43ba53fb0c23"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Vomiting</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">23</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">19</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_7085b3bb-1d0f-4273-b595-08d1d0567215"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Stomatitis</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">17</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">3</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_7497711a-5460-42d5-a493-355635fd8029"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Pruritus</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">13</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">5</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_26f6825e-7a7f-493e-bef0-5852e53ac7a8"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Dry skin</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">12</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">4</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_3065d1c6-d5df-4033-b3be-90780cf2070c"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Conjunctivitis</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">12</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_85aa661c-ec87-4fe7-953f-e96a01c6b483"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Keratoconjunctivitis sicca</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">12</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">3</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_c53da2af-b2c9-46fd-87d3-29f84b713091"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Abdominal pain</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">11</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">7</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>Liver function test abnormalities (including elevated alanine aminotransferase (ALT), aspartate aminotransferase (AST) and bilirubin) were observed in patients receiving single-agent TARCEVA 150 mg. These elevations were mainly transient or associated with liver metastases. Grade 2 (>2.5 â 5.0 x ULN) ALT elevations occurred in 4% and <1% of TARCEVA and placebo treated patients, respectively. Grade 3 (>5.0 â 20.0 x ULN) elevations were not observed in TARCEVA-treated patients. TARCEVA dosing should be interrupted or discontinued if changes in liver function are severeÂ  [see Dosage and Administration (2.3)].<BR>                        <BR>                        <BR>                           Pancreatic Cancer<BR>                        <BR>                        Adverse reactions, regardless of causality, that occurred in at least 10% of patients treated with TARCEVA 100 mg plus gemcitabine in the randomized trial of patients with pancreatic cancer are summarized by NCI-CTC (version 2.0) Grade in Table 3.<BR>                        The most common adverse reactions in pancreatic cancer patients receiving TARCEVA 100 mg plus gemcitabine were fatigue, rash, nausea, anorexia and diarrhea. In the TARCEVA plus gemcitabine arm, Grade 3/4 rash and diarrhea were each reported in 5% of TARCEVA plus gemcitabine-treated patients. The median time to onset of rash and diarrhea was 10 days and 15 days, respectively. Rash and diarrhea each resulted in dose reductions in 2% of patients, and resulted in study discontinuation in up to 1% of patients receiving TARCEVA plus gemcitabine. The 150 mg cohort was associated with a higher rate of certain class-specific adverse reactions including rash and required more frequent dose reduction or interruption.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="single" width="406.000" ID="id_71206161-75d1-48a6-a31c-c3d8fc320fd2"><BR>                           <caption ID="id_932b693d-f436-40f3-955d-fea5f70a26f2">Table 3: Adverse Reactions Occurring in &#8805; 10% of TARCEVA-treated Pancreatic Cancer Patients: 100 mg cohort </caption><BR>                           <col width="23.9%"/><BR>                           <col width="10.3%"/><BR>                           <col width="13.1%"/><BR>                           <col width="13.5%"/><BR>                           <col width="10.8%"/><BR>                           <col width="13.5%"/><BR>                           <col width="14.8%"/><BR>                           <tfoot ID="id_6db8609c-b98b-4479-937e-b5953241dc3a"><BR>                              <tr><BR>                                 <td align="left" valign="top" colspan="7" styleCode="Lrule Botrule Rrule">*Includes all MedDRA preferred terms in the Infections and Infestations System Organ Class</td><BR>                              </tr><BR>                           </tfoot><BR>                           <tbody><BR>                              <tr ID="id_64dd191b-eef5-4707-9ad4-a3488f0e995f"><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Toprule Rrule Lrule"/><BR>                                 <td align="center" valign="bottom" colspan="3" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">TARCEVA + Gemcitabine<br/>1000&#160;mg/m<sup>2</sup> IV<br/>N=259</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" colspan="3" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Placebo + Gemcitabine <br/>1000&#160;mg/m<sup>2</sup> IV<br/>N=256</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_7263273b-dda7-482b-9c2b-416efe8d4e7a"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">NCI-CTC Grade</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Any Grade</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Grade 3</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Grade 4</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Any Grade</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Grade 3</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Grade 4</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_848ff8b1-f10f-44fb-a8b4-45f46ac83794"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule"><BR>                                    <paragraph><BR>                                       <content styleCode="bold">MedDRA</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Preferred&#160;Term</content><BR>                                    </paragraph><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_c5d47dd4-5b90-4539-b90f-7daea5af7cdb"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Fatigue</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">73</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">14</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">70</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">13</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">2</td><BR>                              </tr><BR>                              <tr ID="id_f668ce07-e4e0-428b-8aad-60e46b33b428"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Rash</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">69</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">5</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">30</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_cff21804-27ff-4a40-851e-2197a6f3df8f"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Nausea</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">60</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">7</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">58</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">7</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_3faddd9f-aaba-412b-8bd0-b146548cee25"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Anorexia</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">52</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">6</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">52</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">5</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                              </tr><BR>                              <tr ID="id_cd218b4e-6c0a-4d3e-b885-3721f760a994"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Diarrhea</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">48</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">5</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">36</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_978313af-59c7-4f61-badc-3699826cb1ba"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Abdominal pain</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">46</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">9</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">45</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">12</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                              </tr><BR>                              <tr ID="id_5a4c5cf1-a70d-4b99-82a8-fb8c7770219f"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Vomiting</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">42</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">7</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">41</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">4</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                              </tr><BR>                              <tr ID="id_2d878f1b-93c7-4bb6-841f-63f66d5facee"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Weight decreased</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">39</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">29</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_cbdf87d0-0595-4ed3-a10e-ccec360e7f87"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Infection*</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">39</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">13</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">3</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">30</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">9</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">2</td><BR>                              </tr><BR>                              <tr ID="id_4b6cf65a-4799-49fa-afa0-7018f84b326b"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Edema</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">37</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">3</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">36</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                              </tr><BR>                              <tr ID="id_53445b7e-6b2d-483c-9859-0a31420e78d7"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Pyrexia</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">36</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">3</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">30</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">4</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_98568c63-c21f-44cc-bcaf-d3f2e573884f"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Constipation</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">31</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">3</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">34</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">5</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">1</td><BR>                              </tr><BR>                              <tr ID="id_1d73c8ff-1f16-4119-aefe-2b91a22ee999"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Bone pain</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">25</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">4</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">23</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_ab1a9cf8-6fa5-42cf-a07e-c36d87878c08"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Dyspnea</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">24</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">5</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">23</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">5</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_efa4ebfd-8790-4bc3-8935-84edea226f9d"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Stomatitis</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">22</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">12</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_cd78ca00-b374-4417-8dbc-b8792bd086c5"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Myalgia</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">21</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">20</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_0a3b0fda-6f1f-4e9b-a3c4-d641f5ac174a"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Depression</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">19</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">2</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">14</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_e7a064ce-2f3b-43df-90fc-e9f2afb7b93a"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Dyspepsia</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">17</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">13</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_1ec1f993-dc8b-4e64-accf-ffb0f2016fd5"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Cough</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">16</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">11</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_19e8444e-3b5a-41b6-bca5-4b44032ba1df"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Dizziness</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">15</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">13</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                              </tr><BR>                              <tr ID="id_18c671c1-d2c1-4a29-8f8e-ee029f73b71d"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Headache</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">15</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">10</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_1fef029c-0664-48f4-91f4-d8f85cea579f"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Insomnia</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">15</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">16</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_797bb8de-f5fb-487c-a7e4-c85774b2a007"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Alopecia</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">14</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">11</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_17509241-91b0-4b80-b28e-ddd9f4f784b0"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Anxiety</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">13</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">11</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_a9160e14-502f-4729-89dc-29ba7bfa1963"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Neuropathy</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">13</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">10</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_9068765c-d51b-41e3-b428-09fa240e7210"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Flatulence</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">13</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">9</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">&lt;1</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                              <tr ID="id_3b9086cd-9dea-4f4b-9cd8-2a39e6603aec"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Rigors</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">12</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Rrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">9</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">0</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>In the pancreatic carcinoma trial, 10 patients in the TARCEVA/gemcitabine group developed deep venous thrombosis (incidence: 3.9%). In comparison, 3 patients in the placebo/gemcitabine group developed deep venous thrombosis (incidence 1.2%). The overall incidence of grade 3 or 4 thrombotic events, including deep venous thrombosis, was similar in the two treatment arms: 11% for TARCEVA plus gemcitabine and 9% for placebo plus gemcitabine.<BR>                        No differences in Grade 3 or Grade 4 hematologic laboratory toxicities were detected between the TARCEVA plus gemcitabine group compared to the placebo plus gemcitabine group.<BR>                        Severe adverse reactions (â¥grade 3 NCI-CTC) in the TARCEVA plus gemcitabine group with incidences < 5% included syncope, arrhythmias, ileus, pancreatitis, hemolytic anemia including microangiopathic hemolytic anemia with thrombocytopenia, myocardial infarction/ischemia, cerebrovascular accidents including cerebral hemorrhage, and renal insufficiency [see Warnings and Precautions (5)].<BR>                        <BR>                        Liver function test abnormalities (including elevated alanine aminotransferase (ALT), aspartate aminotransferase (AST) and bilirubin) have been observed following the administration of TARCEVA plus gemcitabine in patients with pancreatic cancer. Table 4 displays the most severe NCI-CTC grade of liver function abnormalities that developed. TARCEVA dosing should be interrupted or discontinued if changes in liver function are severe [see Dosage and Administration (2.3)].<BR>                        <BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="single" width="412.000" ID="id_befee472-d4c6-4522-b726-fa7d5db482e9"><BR>                           <caption ID="id_457e860b-82c0-4f40-8777-e4391601e5e7">Table 4: Liver Function Test Abnormalities (most severe NCI-CTC grade) in Pancreatic Cancer Patients: 100 mg Cohort</caption><BR>                           <col width="15.0%"/><BR>                           <col width="15.3%"/><BR>                           <col width="12.1%"/><BR>                           <col width="13.1%"/><BR>                           <col width="15.0%"/><BR>                           <col width="13.3%"/><BR>                           <col width="16.0%"/><BR>                           <tbody><BR>                              <tr ID="id_745313b3-18b5-4246-8917-bb8565be4cbc"><BR>                                 <td align="left" valign="bottom" styleCode="Botrule Toprule Rrule Lrule"/><BR>                                 <td align="center" valign="bottom" colspan="3" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">TARCEVA + Gemcitabine<br/>1000 mg/m<sup>2</sup> IV<br/>N = 259</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" colspan="3" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Placebo + Gemcitabine<br/>1000 mg/m<sup>2</sup> IV<br/>N = 256</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_43d58695-fee0-4a14-996b-d8158b211493"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule Rrule"><BR>                                    <content styleCode="bold">NCI-CTC Grade</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Grade 2</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Grade 3</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Grade 4</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Grade 2</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule"><BR>                                    <content styleCode="bold">Grade 3</content><BR>                                 </td><BR>                                 <td align="center" valign="bottom" styleCode="Botrule Rrule"><BR>                                    <content styleCode="bold">Grade 4</content><BR>                                 </td><BR>                              </tr><BR>                              <tr ID="id_1b8428d3-fbe1-477e-9ef3-557e73dc6139"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">Bilirubin</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">17 %</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">10%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">11%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">10%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">3%</td><BR>                              </tr><BR>                              <tr ID="id_9d87f9a0-3ad3-40e2-b406-1dee3881cf8a"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">ALT</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">31% </td><BR>                                 <td align="center" valign="top" styleCode="Botrule">13%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">&lt;1%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">22%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">9%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0%</td><BR>                              </tr><BR>                              <tr ID="id_ba19c49c-934c-42d2-8634-9ebc02e2c055"><BR>                                 <td align="left" valign="top" styleCode="Lrule Botrule Rrule">AST</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">24%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">10%</td><BR>                                 <td align="center" valign="top" styleCode="Rrule">&lt;1%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">19%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule">9%</td><BR>                                 <td align="center" valign="top" styleCode="Botrule Rrule">0%</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR><BR>                           NSCLC and Pancreatic Indications: Low Frequency Adverse Reactions<BR>                        <BR>                        <BR>                           Gastrointestinal Disorders<BR>                        <BR>                        Gastrointestinal perforations have been reported [see Warnings and Precautions (5.5)].<BR>                        <BR>                        Cases of gastrointestinal bleeding (including fatalities) have been reported, some associated with concomitant warfarin or NSAID administration [see Warnings and Precautions (5.11) and Drug Interactions (7)]. These adverse reactions were reported as peptic ulcer bleeding (gastritis, gastroduodenal ulcers), hematemesis, hematochezia, melena and hemorrhage from possible colitis. <BR>                        <BR>                           Renal Disorders<BR>                        <BR>                        Cases of acute renal failure or renal insufficiency, including fatalities, with or without hypokalemia have been reported [see Warnings and Precautions (5.2)].Â <BR>                        <BR>                        <BR>                           Hepatic Disorders<BR>                        <BR>                        Hepatic failure has been reported in patients treated with single-agent TARCEVA or TARCEVA combined with chemotherapy [see Warnings and Precautions (5.3)].<BR>                        <BR>                        <BR>                           Ocular Disorders<BR>                        <BR>                        Corneal ulcerations or perforations have been reported in patients receiving TARCEVA treatment. Abnormal eyelash growth including in-growing eyelashes, excessive growth and thickening of the eyelashes have been reported [see Warnings and Precautions (5.10)] and are risk factors for corneal ulceration/perforation. <BR>                        NCI-CTC Grade 3 conjunctivitis and keratitis have been reported infrequently in patients receiving TARCEVA therapy in the NSCLC and pancreatic cancer clinical trials. [see Patient Counseling Information (17)].<BR>                        <BR>                        <BR>                           Skin, Hair, and Nail Disorders<BR>                        <BR>                        Bullous, blistering and exfoliative skin conditions have been reported including cases suggestive of Stevens-Johnson syndrome/Toxic epidermal necrolysis [see Warnings and Precautions (5.6)].<BR>                        In patients who develop skin rash, the appearance of the rash is typically erythematous and maculopapular and it may resemble acne with follicular pustules, but is histopathologically different. This skin reaction commonly occurs on the face, upper chest and back, but may be more generalized or severe (NCI-CTC Grade 3 or 4) with desquamation. Skin reactions may occur or worsen in sun exposed areas; therefore, the use of sunscreen or avoidance of sun exposure is recommended. Associated symptoms may include itching, tenderness and/or burning. Also, hyperpigmentation or dry skin, with or without digital skin fissures have been reported and in the majority of cases were associated with rash. <BR>                        Hair and nail disorders including alopecia, hirsutism, eyelash/eyebrow (see above) changes, paronychia and brittle and loose nails have been reported.<BR>                        <BR>                           Other Disorders<BR>                        <BR>                        Epistaxis was also reported in both the single-agent NSCLC and the pancreatic cancer clinical trials.<BR>                        In general, no notable differences in the safety of TARCEVA monotherapy or in combination with gemcitabine could be discerned between females or males and between patients younger or older than the age of 65 years [see Use in Specific Populations (8.5 and 8.6)]. The safety of TARCEVA appears similar in Caucasian and Asian patients.<BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.2 Post-Marketing Experience<BR>                     <BR>                        The following adverse reactions have been identified during post approval use of TARCEVA. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.<BR>                        <BR>                           Skin and subcutaneous tissue disorders<BR>                        <BR>                        Hair and nail changes, mostly non-serious e.g. hirsutism, eyelash/eyebrow changes, paronychia and brittle and loose nails. Bullous, blistering and exfoliative skin conditions have been reported including cases suggestive of Stevens-Johnson syndrome/Toxic epidermal necrolysis [see Warnings and Precautions (5.6)].<BR>                        <BR>                           Gastrointestinal Disorders<BR>                        <BR>                        Gastrointestinal perforations [see Warnings and Precautions (5.5)].<BR>                        <BR>                           Hepatic Disorders<BR>                        <BR>                        Hepatic failure has been reported in patients treated with single-agent TARCEVA or TARCEVA combined with chemotherapy [see Warnings and Precautions (5.3)].<BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>